Different doses of imeglimin for management of type 2 diabetes mellitus: a systematic review, meta-analysis, and meta-regression of randomized clinical trials-Reference-Cited by-同舟云学术

Different doses of imeglimin for management of type 2 diabetes mellitus: a systematic review, meta-analysis, and meta-regression of randomized clinical trials

Published:2023-12-04 Issue:1 Volume:19 Page:89-98
ISSN:1744-6651
Container-title:Expert Review of Endocrinology & Metabolism
language:en
Short-container-title:Expert Review of Endocrinology & Metabolism

Author:

Permana Hikmat¹,Soetedjo Nanny Natalia Mulyani¹,Yanto Theo Audi²,Tendean Marshell¹,Hariyanto Timotius Ivan³^ORCID,Suastika Ketut⁴

Affiliation:

1. Division of Endocrinology, Metabolic Disorders and Diabetes, Department of Internal Medicine, Padjadjaran University, Bandung, West Java, Indonesia

2. Department of Internal Medicine, Faculty of Medicine, Pelita Harapan University, Karawaci, Tangerang, Indonesia

3. Faculty of Medicine, Pelita Harapan University, Karawaci, Tangerang, Indonesia

4. Division of Endocrinology, Metabolic Disorders and Diabetes, Department of Internal Medicine, Udayana University, Denpasar, Bali, Indonesia

Funder

no funding

Publisher

Informa UK Limited

Subject

Endocrinology, Diabetes and Metabolism

Link

https://www.tandfonline.com/doi/pdf/10.1080/17446651.2023.2290488

Reference25 articles.

1. Diagnosis and Classification of Diabetes Mellitus

2. 2. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes—2021

3. Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: Results from the International Diabetes Federation Diabetes Atlas, 9th edition

4. Epidemiology of Type 2 Diabetes – Global Burden of Disease and Forecasted Trends

5. 9. Pharmacologic Approaches to Glycemic Treatment: Standards of Care in Diabetes—2023

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Recent Research Development of Imeglimin as Oral Hypoglycemic Agent (OHA);Diabetes Research: Open Access;2024-07-22

2. Diabetic Elderly with Keeping Less Arteriosclerosis Treated by Imeglimin (Twymeeg);Asploro Journal of Biomedical and Clinical Case Reports;2024-05-28